NanoGSkin – EuroNanoMed3

NanoGSkin is a transversal research project that combines regenerative medicine technologies with nanomedicine products, in a transnational collaboration of public research groups academia, clinical/public health research sector and private companies, from 4 different countries (Spain, France, Italy and Ireland), by joining together tissue engineering, nanotechnology, biotechnology and industrial production.

NanoGSkin project aims to develop an innovative skin substitute that will overcome two of the major drawbacks of severe skin wounds: the urgent need of an effective skin implant in life-threatening situations and avoid/counteract usual bacterial infections. As a solution, NanoGSkin proposes a combination of bioengineered skin substitute incorporating nanoparticles (NPs) encapsulating antibiotics and recombinant human epidermal growth factor (rhEGF) respectively as an advanced chronic wound therapy.

• Researcher:Miguel Alaminos Mingorance
• Group:TEC03-TISSUE ENGINEERING
• Centre: University of Grenada
• Role in the project: Project coordinator
• Duration: 2018 – Ongoing

Project website: https://nanogskin.com/